Industry: Femtech
Femtech startup funding
Women's health investors fund proof: study data, paying customers and a market wider than one condition. We help femtech founders show that proof clearly, then find the funds that back their field.
- Funding data and investor lists for fertility, menopause and maternal care
- Decks and models built around evidence and who pays
- Waveup prepares investor materials for femtech companies: $3B+ raised for 600+ startups since 2014
In short
What is femtech startup funding?
Femtech startup funding is the money women's health companies raise to build and sell apps, tests, devices, care and medicines. It comes from angels, women's health funds, health VCs, growth investors and the venture arms of drug companies. Dealroom counted $772M of femtech venture funding in 2025, so founders compete for a small pool.
- Who it's for
- Fertility, pregnancy, menopause and other women's health companies, pre-seed to Series D+
- What we build
- Investor deck, financial model, valuation, investor list, data room
- Prices
- Deck from $6,000, model from $3,000. Flat fees
- Track record
- $3B+ raised for 600+ startups since 2014
Market data checked on 5 November 2026. Sources are under each section.
Is femtech a growing industry in 2026?
Demand is growing faster than the money. More women seek care for fertility, pregnancy and menopause, while investors back fewer companies with stronger proof.
The opportunity
Conditions that affect women only, mostly or differently have long had little research and few products.
- Menopause care is the newest and fastest-growing part of femtech
- At-home tests now track hormones and the vaginal microbiome
- AI-enabled companies raise at higher valuations than their peers
The problem
Venture investors put about $2B into women's health in the US and Europe in 2025, down from $3.2B in 2024. Its share of all healthcare venture deals fell as well.
Market size
What is the femtech market worth, and who pays?
Galen Growth puts the women's health opportunity at $360 billion. Four needs drive demand:
- Menopause: 26% of women and girls were 50 or older in 2021, up from 22% a decade earlier
- Fertility: about 1 in 6 adults worldwide experience infertility in their lifetime
- Self-pay care: the NHS paid for 28% of UK IVF cycles in 2024, down from 35% in 2019
- Slow diagnosis: endometriosis takes four to twelve years to diagnose, on average
Venture capital
How much are investors putting into femtech in 2026?
Dealroom counted $772M of femtech venture funding in 2025 and forecasts a fall in 2026. Wider counts that include drug developers run higher, so ask which number an investor uses.
raised by femtech startups from January to September 2026
Series D for Midi Health in February 2026, the biggest femtech round of 2026 to September
went to fertility startups in 2025, more than to any other part of femtech
Who invests in femtech startups?
Women's health specialists, health and growth investors, and the venture arms of drug companies. For more names, see our list of healthcare venture capital firms.
Investor database
Healthtech investors in our database
The funds with the most healthtech investments. Pick a stage, or open a fund for its cheque sizes.
Top 5 by healthtech investments
Investments by industry
- Healthtech & Wellness48%
- Biotech24%
- Pharma21%
- Rounds
- Series ASeries BSeries C+
- Average cheque
- $500K–$1M$1M–$3M$3M–$10M$10M–$50M
- Based in
- New York, United States
- Invests in
- East Asia, USA
704 investments in total, 49 tagged Healthtech & Wellness.Open the full fund profile
Investments by industry
- Healthtech & Wellness42%
- Biotech26%
- Pharma18%
- Rounds
- SeedSeries ASeries BSeries C+
- Average cheque
- $100K–$500K$500K–$1M
- Based in
- Cambridge, United States
- Invests in
- Southeast Asia, USA
613 investments in total, 40 tagged Healthtech & Wellness.Open the full fund profile
Investments by industry
- Healthtech & Wellness56%
- Software & Apps12%
- AI & Deep Tech7%
- Rounds
- SeedSeries ASeries BSeries C+
- Average cheque
- $3M–$10M$10M–$50M
- Based in
- San Francisco, USA
- Invests in
- USA
83 investments in total, 38 tagged Healthtech & Wellness.Open the full fund profile
Investments by industry
- Healthtech & Wellness45%
- Biotech30%
- Pharma19%
- Rounds
- Series ASeries BSeries C+
- Average cheque
- $0–$100K$100K–$500K$500K–$1M$1M–$3M$3M–$10M
- Based in
- Menlo Park, United States
- Invests in
- Europe, USA, Canada
382 investments in total, 30 tagged Healthtech & Wellness.Open the full fund profile
Investments by industry
- Software & Apps36%
- AI & Deep Tech17%
- Healthtech & Wellness16%
- Rounds
- SeedSeries ASeries BSeries C+
- Average cheque
- $3M–$10MOver $50M$10M–$50M
- Based in
- Boston, United States
315 investments in total, 27 tagged Healthtech & Wellness.Open the full fund profile
From our investor database.
What holds femtech raises back?
The 56 VCs in our Fundraising 2025 study most often said no over revenue growth, unit economics, burn or missed milestones. Femtech adds four questions of its own.
Proof costs more
Femtech ventures face clinical evidence demands nearly twice as strict as the digital health average, Galen Growth found.
What investors ask
- What clinical proof do you have, and what will this round add?
What your deck shows
- Study results, or a study plan with dates and costs
- The regulatory route you need, and why
The Series A gap
Galen Growth found that 71% of early-stage femtech ventures struggle to raise a Series A.
What investors ask
- What will you have proven by the time you raise again?
What your deck shows
- Revenue or study results due before the cash runs out
- A shortlist of Series A leads who back your field
Seen as a niche
Femtech took 0.6% of health venture funding so far in 2026, down from 2.2% in 2016, by Dealroom's count.
What investors ask
- Is the market big enough for a fund-sized return?
What your deck shows
- Who pays: patients, employers or insurers, and how much
- Market size built from patient numbers and price
Sensitive health data
In 2021, the FTC finalised an order against Flo Health, the fertility-tracking app. It had shared users' health data with analytics firms after promising privacy.
What investors ask
- How do you collect, store and share health data?
What your deck shows
- What data you hold and who can see it
- The privacy rules you follow, such as HIPAA or GDPR
How we help you raise
Flat fees agreed before we start. No success fee on advisory work.
Your evidence, your buyer and your market in one clear story.
Revenue by payer, study costs and runway, month by month.
A range grounded in comparable women's health rounds and exits.
Women's health funds, health VCs and corporate investors for your stage.
Study data, regulatory files and privacy policies, ready for review.
For a sale to a medtech, pharma or care company.
Who we are
Waveup is a London-based fundraising and growth advisory, working in 60+ countries and 90+ industries. Since 2014 we have built the decks, models, CIMs and valuations behind $3B+ raised for 600+ startups. We work with companies from pre-seed to Series D+.
About usFemtech startup funding FAQ
What is femtech?
How do femtech startups get funding?
Do VCs still invest in femtech in 2026?
What are the leading femtech companies?
What do investors look for in a femtech startup?
How much does help with a femtech raise cost?
Raising for a femtech company?
Share your stage, your evidence and who pays. We'll point out the gaps investors will probe first.



